Brivaracetam Tablets I.P. 50 mg (Brivinift 50)

Brivaracetam Tablets I.P. 50 mg (Brivinift 50) marketed under the brand name Brivinift 50 are an antiepileptic medicine containing Brivaracetam 50 mg. The product is associated with Curavax Pharmaceuticals Pvt. Ltd. and is intended for use under the direction and supervision of a qualified healthcare professional.

Product Overview

What is Brivaracetam 50 mg (Brivinift 50)?

Brivaracetam is an antiepileptic medicine used to help control partial onset seizures. It has a high and selective affinity for synaptic vesicle protein 2A in the brain. Although the precise mechanism responsible for its anticonvulsant activity is not completely established interaction with SV2A is believed to contribute to its seizure controlling effects.

Brivinift 50 contains 50 mg of brivaracetam and is designed for oral administration.

Uses of Brivaracetam Tablets 50 mg (Brivinift 50)

Brivaracetam tablets are primarily used for the treatment of:

• Partial onset seizures
• Focal onset seizures
• Seizures associated with epilepsy as prescribed by a healthcare professional

How Does Brivaracetam (Brivinift 50) Work ?

Brivaracetam acts on a protein called synaptic vesicle protein 2A  in the brain. It has a high and selective affinity for this protein. The exact relationship between SV2A binding and seizure control is not fully understood but this activity is considered an important part of brivaracetam’s anticonvulsant effect.

Brivaracetam 50 mg (Brivinift 50) Dosage

For adults and patients aged 16 years and older current prescribing information lists 50 mg twice daily as a recommended starting dose for monotherapy or adjunctive therapy. Depending on individual response and tolerability the dose may be adjusted to between 25 mg twice daily and 100 mg twice daily.

How to Take Brivinift 50 (Brivinift 50)?

Brivinift 50 should be taken exactly as prescribed.

General administration guidance includes:

• Take the tablet orally with water.
• Follow the dosing schedule provided by the doctor.
• Take doses at approximately the prescribed times each day.
• Do not take an extra dose to compensate for a missed dose without medical advice.
• Do not discontinue the medicine suddenly unless specifically instructed by a healthcare professional.

Common Side Effects of Brivaracetam (Brivinift 50)

Reported adverse effects and clinically important reactions include:

• Sleepiness or somnolence
• Fatigue
• Dizziness
• Nausea
• Headache
• Irritability
• Changes in mood or behavior

Warnings and Precautions

Brivaracetam (Brivinift 50) should be used carefully and under appropriate medical supervision.

1. Drowsiness and Fatigue

Brivaracetam (Brivinift 50) can cause somnolence and fatigue. Patients should be cautious with driving or operating machinery until they know how the medicine affects them.

2. Behavioral and Psychiatric Reactions

Some patients may experience behavioral or psychiatric symptoms, including irritability, anxiety, depression, aggression, or psychotic symptoms. Such symptoms should be reported to a healthcare professional.

3. Suicidal Thoughts or Behavior

Patients taking antiepileptic medicines should be monitored for suicidal thoughts or behavior. Any concerning change in mood or behavior requires prompt medical attention.

4. Allergic Reactions

Hypersensitivity reactions can occur. Serious allergic reactions may include bronchospasm or angioedema. Immediate medical attention is required if symptoms of a serious allergic reaction develop.

5. Skin Reactions

Serious dermatologic reactions have been reported in prescribing information. Patients developing a concerning skin reaction should receive prompt medical assessment.

6. Do Not Stop Abruptly

Antiepileptic medicines should generally be withdrawn gradually when treatment is discontinued. Sudden discontinuation of brivaracetam should be avoided unless medically necessary.

Brivaracetam Drug Interactions

Brivaracetam can interact with other medicines. The prescribing information includes interaction considerations involving medicines such as rifampin, carbamazepine, phenytoin, and levetiracetam.

Patients should tell their doctor about all prescription medicines, over-the-counter medicines, supplements, and other treatments they are using before starting Brivinift 50.

Brivaracetam and Alcohol

Alcohol may increase effects such as impaired attention, psychomotor performance, and memory when used with brivaracetam. Patients should discuss alcohol consumption with their healthcare professional.

Brivaracetam (Brivinift 50) in Pregnancy and Breastfeeding

Patients who are pregnant, planning pregnancy, or breastfeeding should consult their healthcare professional before using Brivaracetam.

The decision to use an antiepileptic medicine during pregnancy or breastfeeding requires consideration of the individual patient’s seizure control and potential risks and benefits.

Brivaracetam (Brivinift 50) in Liver or Kidney Problems

Patients with liver or kidney-related medical conditions should inform their healthcare provider before treatment.

Current prescribing information recommends dose adjustment for hepatic impairment.

The appropriate treatment plan should therefore be determined according to the patient’s clinical condition.

Storage of Brivinift 50

Brivaracetam tablets should be stored according to the storage instructions provided on the product packaging and product information.

Keep medicines:

• In their original packaging.
• Away from excessive heat and moisture.
• Out of reach of children.
• According to the temperature and storage conditions specified on the product label.

Why Brivaracetam 50 mg (Brivinift 50) Is Used in Epilepsy Management

Brivaracetam provides an antiepileptic treatment option with selective affinity for SV2A making it a medicine used in the management of partial onset seizures.

Brivinift 50 by Curavax Pharmaceuticals Pvt. Ltd.

Curavax Pharmaceuticals Pvt. Ltd. offers Brivinift 50 containing Brivaracetam Tablets I.P. 50 mg, as part of its pharmaceutical product portfolio.

Product Highlights

• Brand: Brivinift 50
• Composition: Brivaracetam 50 mg
• Dosage Form: Tablets
• Therapeutic Category: Antiepileptic
• Indication: Partial-onset seizures
• Administration: Oral
• Manufacturer/Company: Curavax Pharmaceuticals Pvt. Ltd.

Frequently Asked Questions

What is Brivinift 50?

Brivinift 50 is a brand of Brivaracetam 50 mg tablets an antiepileptic medicine used for the management of partial-onset seizures under medical supervision.

What is Brivaracetam 50 mg (Brivinift 50) used for?

Brivaracetam 50 mg is used for the treatment of partial onset seizures.

Is Brivinift 50 a prescription medicine?

Yes. Brivaracetam should be used under the direction of a qualified healthcare professional.

Can Brivaracetam be stopped suddenly?

Patients should not stop brivaracetam abruptly without medical advice. Antiepileptic therapy is generally withdrawn gradually when discontinuation is appropriate.

Can Brivaracetam cause sleepiness?

Yes. Somnolence and fatigue are recognized adverse reactions, so patients should take appropriate precautions with driving and machinery.

What is the composition of Brivinift 50?

Brivinift 50 contains Brivaracetam 50 mg.

Conclusion

Brivaracetam Tablets I.P. 50 mg (Brivinift 50) by Curavax Pharmaceuticals Pvt. Ltd. contain brivaracetam an antiepileptic medicine used in the management of partial onset seizures. Brivaracetam has a high and selective affinity for SV2A in the brain and is available in oral tablet formulations.